
Germany · Research startup
infinit Bio is a biotechnology company based in Berlin, Germany, that focuses on bio-manufacturing psychedelics at a large scale.
Funding reportedLast round: Seed
infinit Bio is a biotechnology company based in Berlin, Germany, that focuses on bio-manufacturing psychedelics at a large scale.
Founded in 2021, the company operates with a small team and is publicly traded. The name "infinit Bio" reflects its commitment to infinite opportunities in optimization and its foundation in synthetic biology. The mission of infinit Bio is to innovate and manufacture life-changing medicines for mental health therapies. The company emphasizes high quality and consistency in its products while adhering to sustainable manufacturing practices. Their core technology involves engineering biosynthesis for psychedelics in controlled environments, allowing for scalable production, continuous optimization, and environmentally responsible practices. infinit Bio specializes in biotechnology research, psychedelics manufacturing, and the production of active pharmaceutical ingredients, including psilocybin and related compounds. The company places a strong emphasis on science, which is central to its identity and operations.
Funding, as reported
What they build
Known for
apibiotechnology researchmanufacturingmechanical or industrial engineeringbiotechbiosynthesispsilocybinpsychedelicssynbio
Add your raise, your deck and your story, and put infinit Bio in front of investors. Or tell us what we have wrong.